Safetec of America, Inc. Announces EPA-Registered, Germicidal Wipe

Article

BUFFALO, N.Y. -- Safetec of America, Inc. announces the addition of SaniZide Plus™ Germicidal Disinfectant Wipes to its family of surface disinfectants and cleaners.

Safetec’s SaniZide Plus™ Germicidal wipes is a ready-to-use, hospital-grade surface disinfectant, decontaminant, cleaner and deodorizer.  SaniZide Plus™ wipes are Environmental Protection Agency (EPA)-registered to kill tuberculosis, HIV-1, MRSA, VRE and more. The alcohol-free, non-corrosive formula is non-flammable, safe to ship and will not damage hard, non-porous surfaces.  SaniZide Plus™ Germicidal wipes are available in 160-count or 40-count canisters.

Source: Safetec of America, Inc.

Related Videos
Baby visiting a pediatric facility (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud (Adobe Stock 460719898 by Colored Lights)
Related Content
Pathogens must be eliminated with proper cleaning and infection prevention. (Adobe Stock unknown)

Enhanced Infection Prevention Needed in Health Care Facilities Amid Growing Pathogen Threats

April 19th 2024
Article

Amid escalating multidrug-resistant organism threats, hospitals face business risks and patient trust erosion, necessitating improved cleaning and infection prevention practices.

Paper with words Multidrug-resistant organism (MDO). (Adobe Stock 755358741 by MdBabul)

“It Takes a Village”: Preventing MDRO Spread Through Public Health Partnerships

April 19th 2024
Article

Tisha Mitsunaga, DrPH, ScM, discusses innovative approaches fostering collaboration between public health and healthcare facilities to combat multidrug-resistant organism (MDRO) spread.

Clostridioides difficile (Adobe Stock 260659307 by gaetan)

Navigating Clostridioides difficile Testing Guidelines: Addressing Adherence Challenges in Health Care Settings

April 18th 2024
Article

A study presented at the Society for Healthcare Epidemiology of America (SHEA) conference evaluated adherence to laxative administration guidelines before CDI testing in Veteran Affairs (VA) hospitals and explored associated demographic and contextual factors.

The FDA sign. (Adobe Stock 323811316 by JHVEPhoto)

GSK's 5-in-1 Meningococcal Vaccine Candidate BLA Accepted by FDA: A Potential Game-Changer in IMD Prevention

April 16th 2024
Article

The FDA has accepted GSK's BLA for a 5-in-1 meningococcal vaccine candidate, which promises streamlined immunization and a potential reduction in invasive meningococcal disease (IMD).

CDC on a laptop (Adobe Stock unknown)

CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing

April 15th 2024
Article

Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.

Cows have been found to be infected with H5N1. (Adobe Stock 10402324 by AF)

Understanding and Mitigating H5N1, Avian Flu Risks in Cattle and Beyond: Insights from Ramon Zegpi Lagos, DVM, PhD

April 12th 2024
Article

Ramon Zegpi Lagos, DVM, PhD, discusses H5N1 (avian flu), risks, transmission dynamics, preventive measures, and ongoing research at The Ohio State University.